PDA Laboratories continues to strengthen its position as a trusted third-party testing partner for manufacturers across the cosmetics, nutraceutical, and pharmaceutical sectors.
Operating from its Riverdale, New Jersey facility, the company has expanded testing capabilities making capital investments into testing equipment, strengthening expertise, and enhancing services that help clients navigate increasingly complex regulatory expectations.
Since its establishment, PDA Laboratories has focused on combining scientific accuracy with responsive support. The company’s approach centers on delivering dependable microbiology and analytical testing while helping manufacturers and packaging companies protect product quality, consumer safety, and brand reputation. Its continued growth reflects a commitment to practical solutions that address real production challenges.
Building a Broader Testing Portfolio
Over the past year, PDA Laboratories has expanded several core capabilities. The company’s analytical division continues to provide high-performance liquid chromatography, gas chromatography, method validations, method verifications, and method development services.
New initiatives include studies involving emerging ingredients and specialized testing requirements, allowing PDA to support manufacturers developing innovative products.
-
We make sure that formulas are safe, the products are clean, and that there are no pathogens that could harm the end client or ruin the product.
The laboratory has also strengthened its stability testing program with new chambers offering real-time and accelerated stability conditions. Additional storage capabilities enable clients to evaluate product performance under controlled environments while meeting regulatory requirements. These investments demonstrate PDA Laboratories’ focus on helping companies make informed decisions throughout product development and commercialization.
In June 2026, the U.S. Food and Drug Administration approved bemotrizinol as the first new active sunscreen ingredient in over 20 years. PDA Laboratories analytical team is currently testing this active sunscreen ingredient for several skin care companies.
Advancing Microbiology and Quality Assurance
Microbiology remains central to PDA Laboratories’ services. The company continues expanding its environmental monitoring programs, developing protocols and utilizing super air samplers and contact plates to manage alert and action limits on detection. In addition, the preservative effectiveness testing and antimicrobial effectiveness testing department have also grown, supporting USP 51 and PCPC single and double challenge testing programs.
PDA Laboratories further supports clients through facility assessments, microbial identification, contamination investigations, and production environment evaluations. Its team works closely with manufacturers and packagers when challenges arise, providing technical guidance rather than simply delivering test results.
“We make sure that formulas are safe, the products are clean, and that there are no pathogens that could harm the end client or ruin the product,” says James Seijas, Vice President of Operations.
Strengthening Trust through Compliance
Regulatory excellence remains a foundation of PDA Laboratories’ operations. The company recently achieved ISO 17025 recertification, reinforcing its commitment to quality systems, technical competence, and reliable testing practices. PDA has also expanded its controlled substance testing program through its DEA license and continues investing in personnel to support growing demand.
Recent team expansion includes additional microbiology technicians and analytical expertise, enabling the company to increase capacity while maintaining service standards. With approximately 20 percent annual growth, PDA Laboratories continues building its reputation through client retention, referrals, and consistent execution.
Delivering Value beyond Testing
PDA Laboratories differentiates itself through pricing, communication, turnaround time, and dependable execution. The company emphasizes clear reporting processes, low revision rates, and predictable service timelines to help clients make timely decisions. Its courier service further improves convenience by enabling sample pickup and same-day laboratory onboarding for eligible clients within its service area. Preliminary reports, which provide vital information on testing progress, may be available in three days for certain tests. This report is included in the testing process for the sponsor.
Looking ahead, PDA Laboratories remains focused on expanding its reach, capabilities, and industry visibility. By combining advanced scientific resources with personalized client support, the company continues to help manufacturers create safer, compliant products. Through ongoing investment and disciplined execution, PDA Laboratories is positioned to support the evolving needs of the microbiology testing services market.
The laboratory’s continued momentum reflects a broader vision of partnership, where scientific expertise and operational responsiveness work together to address industry demands. As manufacturers seek reliable testing partners, PDA Laboratories remains dedicated to advancing quality, strengthening confidence, and delivering solutions that support safer products and sustainable success worldwide.
Protecting Release Timelines through Better Microbiology Testing
A microbiology result that arrives late can hold a release decision in place even when every other quality check is complete. The deeper buying problem is repeat work. Poor sample intake or avoidable report revisions can turn an apparently fast laboratory into a source of delay. Executives evaluating an outside testing partner should look past the test menu and ask how reliably work moves from receipt through reporting under routine production pressure.
Technical fit starts with the methods a laboratory can perform consistently, not the number of services on its website. Environmental monitoring and preservative effectiveness work place different demands on sampling, media selection, incubation controls and interpretation. The laboratory should be able to explain how it handles those differences without introducing unnecessary variation between runs. For buyers in regulated life sciences, the useful distinction is whether procedures produce records that can support internal quality review and external inspection without creating a second round of clarification.
“PDA’s microbiology work includes environmental monitoring using air samplers and contact plates, plus preservative effectiveness and antimicrobial effectiveness testing under USP 51 and PCPC challenge methods.”
Sample movement can be just as consequential as bench work. Environmental monitoring samples may spend time in transit before plating, while routine submissions can lose days through intake backlogs or incomplete handoffs. Buyers should examine how quickly samples enter the laboratory workflow and whether assigned due dates reflect real capacity. Reporting discipline matters too. Preliminary results should arrive when promised and final reports should not routinely require correction. A low revision burden reduces the administrative drag placed on quality staff after the analytical work is finished.
Accreditation provides a reference point, but its practical value depends on how the laboratory applies its quality system between audits. Staffing depth, controlled procedures, training records and workload management offer a clearer view of whether service levels can be sustained as volume changes. An accredited laboratory that accepts more work than its bench can absorb may still miss deadlines. Procurement teams should therefore connect certification status to current staffing capacity rather than treating the certificate itself as a complete proxy for performance.
The strongest selection process tests these factors against the buyer’s own workflow. A provider may have the correct microbiology methods yet still be a poor fit if pickup arrangements or reporting practices create friction for the client. Contract terms and price matter, but they should be considered along with revision frequency and the laboratory’s ability to keep promised dates. The better fit is the laboratory whose technical scope is supported by a service model that remains predictable once routine volume begins.
PDA merits consideration for buyers that need microbiology testing tied closely to dependable sample handling and reporting. Its microbiology work includes environmental monitoring using air samplers and contact plates, plus preservative effectiveness and antimicrobial effectiveness testing under USP 51 and PCPC challenge methods. PDA has also added microbiology technicians and expanded its courier service for established clients within its service radius, allowing collected samples to be brought into the laboratory and plated the same day. Its ISO 17025 recertification gives buyers a quality-system reference point. For teams comparing laboratories on execution rather than test menus alone, this combination is relevant.
...Read more
